Citations

Showing 10 of 108119 citations.

Sex-Based Differences in Outcomes With Percutaneous Transcatheter Repair of Mitral Regurgitation With the MitraClip System: Transcatheter Valve Therapy Registry From 2011 to 2017
Villablanca, Pedro , Vemulapalli, Sreekanth , Stebbins, Amanda , Dai, Dadi, So, Chak-Yu , Eng, Marvin H. , Wang, Dee Dee , Frisoli, Tiberio , Lee, James , Kang, Guson , Ibrahim, Homam , Staniloae, Cezar , Gaba, Prakriti , Lemor, Alejandro , Finn, Matthew , Leon, Martin B. , Villablanca, Pedro A , Lee, James C , Staniloae, Cezar , Lemor, Alejandro , Ramakrishna, Harish , Shah, Binita , Wang, Dee Dee , Szerlip, Molly , Williams, Mathew , O’Neill, William W. , Shah, Binita

Mayo Clinic

Circulation: Cardiovascular Interventions | November 16, 2021 | Volume: 14 | Issue: 11 | Pages: No page available

10.1161/circinterventions.120.009374 | PMID 34784236 Get It

Background: Women have a higher rate of adverse events after mitral valve surgery. We sought to evaluate whether outcomes after transcatheter edge-to-edge repair intervention by sex have similar trends to mitral valve surgery. Methods: The primary outcome was 1-year major adverse events defined as a composite of all-cause mortality, stroke, and any bleeding in the overall study cohort. Patients who underwent transcatheter edge-to-edge repair for mitral regurgitation with the MitraClip system in the Society of Thoracic Surgery/American College of Cardiology Transcatheter Valve Therapy registry were evaluated. Linked administrative claims from the Centers for Medicare and Medicaid Services were used to evaluate 1-year clinical outcomes. Associations between sex and outcomes were evaluated using a multivariable logistic regression model for in-hospital outcomes and Cox model for 1-year outcomes. Results: From November 2013 to March 2017, 5295 patients, 47.6% (n=2523) of whom were female, underwent transcatheter edge-to-edge repair. Females were less likely to have >1 clip implanted ( P <0.001) and had a lower adjusted odds ratio of device success (adjusted odds ratio, 0.78 [95% CI, 0.67–0.90]), driven by lower odds of residual mitral gradient <5 mm Hg (adjusted odds ratio, 0.54 [CI, 0.46–0.63]) when compared with males. At 1-year follow-up, the primary outcome did not differ by sex. Female sex was associated with lower adjusted 1-year risk of all-cause mortality (adjusted hazard ratio, 0.80 [CI, 0.68–0.94]), but the adjusted 1-year risk of stroke and any bleeding did not differ by sex. Conclusions: No difference in composite outcome of all-cause mortality, stroke, and any bleeding was observed between females and males. Adjusted 1-year all-cause mortality was lower in females compared with males.
A scalable 3D tissue culture pipeline to enable functional therapeutic screening for pulmonary fibrosis
Cummins, Katherine A. , Bitterman, Peter B. , Tschumperlin, Daniel J. , Wood, David K.

Mayo Clinic

APL Bioengineering | November 16, 2021 | Volume: 5 | Issue: 4 | Pages: No page available

10.1063/5.0054967 | PMID 34805716 Get It

Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease targeting the alveolar gas exchange apparatus, leading to death by asphyxiation. IPF progresses on a tissue scale through aberrant matrix remodeling, enhanced cell contraction, and subsequent microenvironment densification. Although two pharmaceuticals modestly slow progression, IPF patient survival averages less than 5 years. A major impediment to therapeutic development is the lack of high-fidelity models that account for the fibrotic microenvironment. Our goal is to create a three-dimensional (3D) platform to enable lung fibrosis studies and recapitulate IPF tissue features. We demonstrate that normal lung fibroblasts encapsulated in collagen microspheres can be pushed toward an activated phenotype, treated with FDA-approved therapies, and their fibrotic function quantified using imaging assays (extracellular matrix deposition, contractile protein expression, and microenvironment compaction). Highlighting the system's utility, we further show that fibroblasts isolated from IPF patient lungs maintain fibrotic phenotypes and manifest reduced fibrotic function when treated with epigenetic modifiers. Our system enables enhanced screening due to improved predictability and fidelity compared to 2D systems combined with superior tractability and throughput compared to 3D systems.
Quality of Life and Exercise Ability in Heart Failure With Preserved Ejection Fraction
Redfield, Margaret M. , Borlaug, Barry A.

Mayo Clinic

JAMA | November 16, 2021 | Volume: 326 | Issue: 19 | Pages: 1913

10.1001/jama.2021.15874 | PMID 34783856 Get It

Empowering Women as Leaders in Pediatric Anesthesiology: Methodology, Lessons, and Early Outcomes of a National Initiative
Schwartz, Jamie McElrath , Markowitz, Scott D. , Yanofsky, Samuel D., Tackett, Sean , Berenstain, Laura K. , Schwartz, Lawrence , Flick, Randall P., Heitmiller, Eugenie S., Fiadjoe, John E. , Lee, Helen H. , Honkanen, Anita , Malviya, Shobha , Cladis, Franklyn P. , Lee, Jennifer K. , Flick, Randall, Deutsch, Nina

Mayo Clinic

Anesthesia & Analgesia | November 16, 2021 | Volume: 133 | Issue: 6 | Pages: 1497-1509

10.1213/ane.0000000000005740 | PMID 34517375 Get It

Research has shown that women have leadership ability equal to or better than that of their male counterparts, yet proportionally fewer women than men achieve leadership positions and promotion in medicine. The Women’s Empowerment and Leadership Initiative (WELI) was founded within the Society for Pediatric Anesthesia (SPA) in 2018 as a multidimensional program to help address the significant career development, leadership, and promotion gender gap between men and women in anesthesiology. Herein, we describe WELI’s development and implementation with an early assessment of effectiveness at 2 years. Members received an anonymous, voluntary survey by e-mail to assess whether they believed WELI was beneficial in several broad domains: career development, networking, project implementation and completion, goal setting, mentorship, well-being, and promotion and leadership. The response rate was 60.5% (92 of 152). The majority ranked several aspects of WELI to be very or extremely valuable, including the protégé-advisor dyads, workshops, nomination to join WELI, and virtual facilitated networking. For most members, WELI helped to improve optimism about their professional future. Most also reported that WELI somewhat or absolutely contributed to project improvement or completion, finding new collaborators, and obtaining invitations to be visiting speakers. Among those who applied for promotion or leadership positions, 51% found WELI to be somewhat or absolutely valuable to their application process, and 42% found the same in applying for leadership positions. Qualitative analysis of free-text survey responses identified 5 main themes: (1) feelings of empowerment and confidence, (2) acquisition of new skills in mentoring, coaching, career development, and project implementation, (3) clarification and focus on goal setting, (4) creating meaningful connections through networking, and (5) challenges from coronavirus disease 2019 (COVID-19) and the inability to sustain the advisor-protégé connection. We conclude that after 2 years, the WELI program has successfully supported career development for the majority of protégés and advisors. Continued assessment of whether WELI can meaningfully contribute to attainment of promotion and leadership positions will require study across a longer period. WELI could serve as a programmatic example to support women’s career development in other subspecialties.
Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation
Berdichevski, Tania, Garg, Sushil Kumar , Katz, Lior H.

Mayo Clinic

Cochrane Database of Systematic Reviews | November 16, 2021 | Volume: 2021 | Issue: 11 | Pages: No page available

10.1002/14651858.cd010174.pub2 Get It

The immunologic balance: three cases of rituximab-associated melanoma
Davidson, Tara M., Markovic, Svetomir N., Dimou, Anastasios, Davidson, Tara M. , Markovic, Svetomir N., Dimou, Anastasios

Mayo Clinic

Melanoma Research | November 16, 2021 | Volume: 32 | Issue: 1 | Pages: 67-70

10.1097/cmr.0000000000000799 | PMID 34783721 Get It

Currently, there is no known clinical evidence that rituximab increases the rate of subsequent primary malignancies; however, some studies have raised the question of increased melanoma risk following rituximab treatment for non-Hodgkin lymphoma. We report three interesting cases of suspected rituximab-induced melanoma. We hypothesize that this association is secondary to rituximab-driven shifts in the immunologic balance. Based on these cases, it is possible that the number of post-rituximab melanoma cases is underreported. Further mechanistic research into individual cases and population-level studies are required to better define association and risk; however, given the increasing prevalence of oncologic and nononcologic rituximab use, awareness across all fields is essential.
Histone deacetylase 3 represses cholesterol efflux during CD4+ T-cell activation
Wilfahrt, Drew, Philips, Rachael L, Lama, Jyoti, Kizerwetter, Monika , Shapiro, Michael Jeremy, McCue, Shaylene A, Kennedy, Madeleine M, Rajcula, Matthew J, Zeng, Hu, Philips, Rachael L. , Wilfahrt, Drew N. , Lama, Jyoti , Shapiro, Virginia S , Lama, Jyoti, Kizerwetter, Monika , Shapiro, Michael Jeremy, McCue, Shaylene A, Kennedy, Madeleine M, Rajcula, Matthew J, Zeng, Hu

Mayo Clinic

eLife | November 16, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.7554/elife.70978 | PMID 34854376 Get It

After antigenic activation, quiescent naive CD4 + T cells alter their metabolism to proliferate. This metabolic shift increases production of nucleotides, amino acids, fatty acids, and sterols. Here, we show that histone deacetylase 3 (HDAC3) is critical for activation of murine peripheral CD4 + T cells. HDAC3-deficient CD4 + T cells failed to proliferate and blast after in vitro TCR/CD28 stimulation. Upon T-cell activation, genes involved in cholesterol biosynthesis are upregulated while genes that promote cholesterol efflux are repressed. HDAC3-deficient CD4 + T cells had reduced levels of cellular cholesterol both before and after activation. HDAC3-deficient cells upregulate cholesterol synthesis appropriately after activation, but fail to repress cholesterol efflux; notably, they overexpress cholesterol efflux transporters ABCA1 and ABCG1. Repression of these genes is the primary function for HDAC3 in peripheral CD4 + T cells, as addition of exogenous cholesterol restored proliferative capacity. Collectively, these findings demonstrate HDAC3 is essential during CD4 + T-cell activation to repress cholesterol efflux.
International expert consensus on precision anatomy for minimally invasive pancreatoduodenectomy: PAM‐HBP surgery project
Nagakawa, Yuichi , Nakata, Kohei , Nishino, Hitoe , Ohtsuka, Takao , Ban, Daisuke , Asbun, Horacio J. , Boggi, Ugo , He, Jin , Kendrick, Michael L. , Palanivelu, Chinnusamy , Liu, Rong , Wang, Shin‐E , Tang, Chung‐Ngai, Takaori, Kyoichi , Hilal, Mohammad Abu , Jang, Jin‐Young , Kang, Chang Moo , Kooby, David A. , Nakamura, Yoshiharu , Shrikhande, Shailesh V. , Wolfgang, Christopher L. , Yiengpruksawan, Anusak, Watanabe, Yusuke , Kozono, Shingo , Ciria, Rubén , Garbarino, Giovanni Maria , Higuchi, Ryota , Ishikawa, Yoshiya , Maekawa, Aya , Murase, Yoshiki, Kunzler, F. , Wang, Zizheng , Sakuma, Leon, Takishita, Chie, Osakabe, Hiroaki , Endo, Itaru , Tanaka, Masao , Yamaue, Hiroki , Tanabe, Minoru , Wakabayashi, Go , Tsuchida, Akihiko , Goh, Brian K P , Honda, Goro , Jang, Jin-Young , Kang, Chang Moo , Yoon, Yoo-Seok , Ciria, Ruben , Kunzler, Filipe , Endo, Itaru , Nakamura, Masafumi , Nakata, Kohei , Tang, Chung Ngai, Honda, Goro , Berardi, Giammauro , Ikenaga, Naoki , Zimmitti, Giuseppe

Mayo Clinic

Journal of Hepato-Biliary-Pancreatic Sciences | November 16, 2021 | Volume: 29 | Issue: 1 | Pages: 124-135

10.1002/jhbp.1081 | PMID 34783176 Get It

AbstractBackgroundThe anatomical structure around the pancreatic head is very complex and it is important to understand its precise anatomy and corresponding anatomical approach to safely perform minimally invasive pancreatoduodenectomy (MIPD). This consensus statement aimed to develop recommendations for elucidating the anatomy and surgical approaches to MIPD.MethodsStudies identified via a comprehensive literature search were classified using the Scottish Intercollegiate Guidelines Network method. Delphi voting was conducted after experts had drafted recommendations, with a goal of obtaining >75% consensus. Experts discussed the revised recommendations with the validation committee and an international audience of 384 attendees. Finalized recommendations were made after a second round of online Delphi voting.ResultsThree clinical questions were addressed, providing six recommendations. All recommendations reached at least a consensus of 75%. Preoperatively evaluating the presence of anatomical variations and superior mesenteric artery (SMA) and superior mesenteric vein (SMV) branching patterns was recommended. Moreover, it was recommended to fully understand the anatomical approach to SMA and intraoperatively confirm the SMA course based on each anatomical landmark before initiating dissection.ConclusionsMIPD experts suggest that surgical trainees perform resection based on precise anatomical landmarks for safe and reliable MIPD.
Pulmonary Metastasectomy in Pediatric Patients: A Comparison of Open and Thoracoscopic Approaches
Traynor, Michael D. , Brar, Gurbir Dimple, Bruno, Fernando , Iyer, Geetha , Ishitani, Michael B., Bruno, Fernando P

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | November 16, 2021 | Volume: 32 | Issue: 1 | Pages: 64-71

10.1089/lap.2021.0439 | PMID 34783259 Get It

Background: Although the use of video-assisted thoracoscopic surgery (VATS) for resection of lung metastases has increased, surgeons still advocate for open resection as it permits palpation of lesions that may be missed on imaging. This study aimed to compare the utilization of open thoracotomy versus VATS over time and determine if the use of VATS changes perioperative outcomes. Methods: Using the Kids' Inpatient Database (2006, 2009, 2012, 2016), we identified children (age ≤20) with a diagnosis of secondary lung cancer with either lobectomy or sublobar resection coded during the same admission. Utilization was compared across years for the overall cohort and for patients with primary bone and connective tissue (PBCT) cancers. We defined prolonged length of stay (LOS) as LOS ≥75th percentile (LOS ≥7 days). Univariable and multivariable analyses compared in-hospital complication rates and LOS for open and VATS approaches. Results: Of the 1316 children (539 female) undergoing pulmonary resection, VATS was utilized in 374 (28.4%). Utilization increased rapidly from 2006 to 2009 ( P < .001 for trend), but stabilized thereafter ( P = .622). Metastatic PBCT cancers were the most common indication for resection ( n = 496, 38%), but open and VATS approaches were used nearly equally ( P = .368). Overall, 352 (26%) patients had complications. On multivariable analysis, the open approach remained independently associated with increased complications (odds ratio [OR] 1.48, 95% confidence interval [CI] [1.04–2.11]). Median LOS increased for open cases (5 versus 3 days, P < .001). Furthermore, open metastasectomy was associated with prolonged LOS (OR 1.50, [1.07–2.10]) after controlling for age, sex, primary cancer, reporting year, resection extent, obesity, complications, and nonoperative intubation. Conclusion: VATS approach to pulmonary metastasectomy resulted in fewer complications and shorter LOS in a nationwide sample of children. Despite these advantages, the use of VATS has plateaued. While this study cannot comment on oncologic safety or long-term outcomes, future studies should evaluate whether indications for VATS pulmonary metastasectomy can be expanded.
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
Sanchorawala, Vaishali , Gertz, Morie A. , Hegenbart, Ute , Landau, Heather , Mollee, Peter , Wechalekar, Ashutosh , Gertz, Morie A , Hegenbart, Ute , Landau, Heather , Sanchorawala, Vaishali , Boccadoro, Mario , Kastritis, Efstathios , Wechalekar, Ashutosh D. , Palladini, Giovanni

Mayo Clinic

Amyloid | November 16, 2021 | Volume: 29 | Issue: 1 | Pages: 1-7

10.1080/13506129.2021.2002841 | PMID 34783272 Get It